Richard Kennedy

Professor

Phone+44 (0)28 9097 2777
Emailr.kennedy@qub.ac.uk

Room 02.018 - H.S.B
United Kingdom

Accepting PhD Students

PhD projects

Precision Medicine Immune Oncology DNA repair

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Statement

The Stratified Medicine Group focuses on the following areas:

1) Characterisation of a molecular group in solid cancers that represents an innate immune response to DNA damage through the STING pathway.

2) Development of a biomarker for anti-angiogenic agents

3) Development of a biomarker for MEKK pathway activation

4) Identification of a prognostic biomarker for early prostate cancer

5) Development of new cell lines for pre-clinical modelling of ovarian and prostate cancer.

Other

Linked in Profile:

https://www.linkedin.com/in/profkennedy/

Fingerprint

Dive into the research topics where Richard Kennedy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

80 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

4 Active
5 Finished

R1005PMY: Artificial Intelligence Enables Clinical Decision Making in the Digital Healthcare Era
McArt, D., Kennedy, R. & Salto-Tellez, M.
12/02/2019 → …
Project: Research
R1938CNR: Development of biomarkers for inhibitors of GRP78, the master regulator of the unfolded protein response, for poor prognostic colorectal cancer subgroups.
Van Schaeybroeck, S. & Kennedy, R.
06/09/2018 → …
Project: Research
R1523CNR: “S-CORT: Stratification in COloRectal cancer: from biology to Treatment prediction”.
Lawler, M., Johnston, P., Kennedy, R., Salto-Tellez, M. & Wilson, R.
29/04/2015 → …
Project: Research
R6416CNR: Phase 1B/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients
Van Schaeybroeck, S., Johnston, P., Kennedy, R., Lawler, M., Longley, D., Salto-Tellez, M. & Wilson, R.
01/08/2013 → …
Project: Research
R2116CNR: MOVEMBER CENTRE OF EXCELLENCE
O'Sullivan, J., Jain, S., Kennedy, R., McDade, S., Prise, K., Salto-Tellez, M. & Waugh, D.
21/05/2014 → 30/06/2019
Project: Research

In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Malla, S. B., Fisher, D. J., Domingo, E., Blake, A., Hassanieh, S., Redmond, K. L., Richman, S. D., Youdell, M., Walker, S. M., Logan, G. E., Chatzipli, A., Amirkhah, R., Humphries, M. P., Craig, S. G., McDermott, U., Seymour, M. T., Morton, D. G., Quirke, P., West, N. P., Salto-Tellez, M. & 12 others, Kennedy, R. D., Johnston, P. G., Tomlinson, I., Koelzer, V. H., Campo, L., Kaplan, R. S., Longley, D. B., Lawler, M., Maughan, T. S., Brown, L. C., Dunne, P. D. & Consortium, S. C., 01 Jan 2021, In : Clinical Cancer Research. 27, 1, p. 288-300
Research output: Contribution to journal › Article › peer-review
ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation
Hanna, C., Dunne, V. L., Walker, S. M., Butterworth, K. T., McCabe, N., Waugh, D. J. J., Kennedy, R. D. & Prise, K. M., 30 Dec 2020, In : Cancers. 13, 1
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Downloads (Pure)
Identification of Src's role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches
McCabe, N. H., Stevenson, L., Scanlon, E., Keminer, O., Kennedy, R., Windshuegel, B., Blayney, J. & Turkington, R. C., 01 Aug 2020, In : Cancer Research. 80, 16 Supplement
Research output: Contribution to journal › Meeting abstract › peer-review
22 Downloads (Pure)
Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches
McCabe, N., Stevenson, L., Scanlon, E., Keminer, O., Kennedy, R., Windshuegel, B., Blayney, J. & Turkington, R., 22 Jun 2020.
Research output: Contribution to conference › Abstract › peer-review
RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer
Khawaja, H., Campbell, A., Roberts, J. Z., Javadi, A., O’Reilly, P., McArt, D., Allen, W. L., Majkut, J., Rehm, M., Bardelli, A., Di Nicolantonio, F., Scott, C. J., Kennedy, R., Vitale, N., Harrison, T., Sansom, O. J., Longley, D. B., Evergren, E. & Van Schaeybroeck, S., 29 Oct 2020, In : Cell death and disease. 11, 10, 18 p., 930.
Research output: Contribution to journal › Article › peer-review

Open Access
File
64 Downloads (Pure)

Queen’s University of Belfast Vice Chancellor Award for Innovation
Kennedy, Richard (Recipient), 2013
Prize: Prize (including medals and awards)
St Luke’s Medal for Cancer Research. Royal College of Medicine, Ireland
Kennedy, Richard (Recipient), 2015
Prize: Prize (including medals and awards)

Behind the Science. 30 minute TV programme on Cancer Research at QUB/Almac
Richard Kennedy
13/12/2017
1 Media contribution
Press/Media: Public Engagement Activities
A visit to the Doctor in 2013. Public lecture.
Richard Kennedy
10/10/2017
1 item of Media coverage
Press/Media: Public Engagement Activities

Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation
Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant) & Daniel Longley (Participant)
Impact: Health Impact, Quality of Life Impact